Literature DB >> 8723417

Neutrophil activation in chronic liver disease.

A J Stanley1, I R MacGregor, J F Dillon, I A Bouchier, P C Hayes.   

Abstract

OBJECTIVE: To assess the relationship between neutrophil activation and indices of disease severity in patients with chronic liver disease.
METHODS: Plasma neutrophil elastase was measured by radioimmunoassay as a marker of neutrophil activation, and disease severity assessed by standard clinical, biochemical, haematological and histological techniques. PATIENTS: Eighty-eight patients with chronic liver disease were studied, Thirty-nine had alcohol-induced liver disease (ALD), 18 autoimmune chronic hepatitis, 13 cryptogenic cirrhosis, seven primary biliary cirrhosis, six primary sclerosing cholangitis, three haemochromatosis and two secondary biliary cirrhosis. Seventy-three patients were cirrhotic and 15 were non-cirrhotic, confirmed by biopsy.
RESULTS: Levels of neutrophil elastase were raised in Childs C cirrhotic patients with ALD compared with Childs A or B patients with ALD (P < 0.01), Childs A or B patients with non-ALD (P < 0.01), and Childs C patients with non-ALD (P = 0.02). In patients with ALD, neutrophil elastase correlated with prothrombin time (r = 0.679, P = 0.001), bilirubin (r = 0.587, P < 0.001), Child-Pugh score (r = 0.546, P < 0.001) and inversely with serum albumin (r = -0.511, P < 0.001). In patients with non-ALD, there were no correlations with the measurements of with transaminase levels.
CONCLUSION: Neutrophil activation, as measured by plasma neutrophil elastase, is a marker of disease severity in patients with alcohol-induced chronic liver damage, but not in those with other causes of liver disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8723417     DOI: 10.1097/00042737-199602000-00008

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  9 in total

1.  The augmented neutrophil respiratory burst in response to Escherichia coli is reduced in liver cirrhosis during infection.

Authors:  T Bruns; J Peter; S Hagel; A Herrmann; A Stallmach
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

2.  Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation.

Authors:  V von Baehr; W D Döcke; M Plauth; C Liebenthal; S Küpferling; H Lochs; R Baumgarten; H D Volk
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

3.  Neutrophil dysfunction predicts 90-day survival in patients with acute on chronic liver failure: A longitudinal case-control study.

Authors:  Kunaal Makkar; Shallu Tomer; Nipun Verma; Sahaj Rathi; Sunil K Arora; Sunil Taneja; Ajay Duseja; Yogesh K Chawla; Radha K Dhiman
Journal:  JGH Open       Date:  2020-05-05

4.  Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis.

Authors:  V Stadlbauer; R P Mookerjee; G A K Wright; N A Davies; G Jürgens; S Hallström; R Jalan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

Review 5.  Innate immune dysfunction in acute and chronic liver disease.

Authors:  Bettina Leber; Ursula Mayrhauser; Michael Rybczynski; Vanessa Stadlbauer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 6.  Immune dysfunction in cirrhosis.

Authors:  Nora Sipeki; Peter Antal-Szalmas; Peter L Lakatos; Maria Papp
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 7.  Bench-to-beside review: acute-on-chronic liver failure - linking the gut, liver and systemic circulation.

Authors:  Len Verbeke; Frederik Nevens; Wim Laleman
Journal:  Crit Care       Date:  2011-10-25       Impact factor: 9.097

Review 8.  Review of Defective NADPH Oxidase Activity and Myeloperoxidase Release in Neutrophils From Patients With Cirrhosis.

Authors:  Richard Moreau; Axel Périanin; Vicente Arroyo
Journal:  Front Immunol       Date:  2019-05-08       Impact factor: 7.561

9.  Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein.

Authors:  Melanie Deutsch; Spilios Manolakopoulos; Ioannis Andreadis; Markos Giannaris; George Kontos; Hariklia Kranidioti; Maria Pirounaki; John Koskinas
Journal:  Ann Gastroenterol       Date:  2017-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.